Stealth BioTherapeutics Announces PDUFA Action Date Extension for Elamipretide to Treat Patients with Barth Syndrome
Hand-out
Press Releases
STEALTH BIOTHERAPEUTICS INC.  
January 23, 2025

Stealth BioTherapeutics Announces PDUFA Action Date Extension for Elamipretide to Treat Patients with Barth Syndrome

– New PDUFA Action Date of April 29, 2025, Allows FDA Additional Time to Complete Review –

avatar profile Olean Times Herald

Olean Times Herald


Local & Social